Grace Science says FDA bottleneck jeopardizes rare disease therapynews2026-06-09T18:22:35+00:00June 9th, 2026|Endpoints News|
A different approach to lowering healthcare costsnews2026-06-09T16:03:56+00:00June 9th, 2026|Endpoints News|
How K Health moved AI chatbots into hospitalsnews2026-06-09T15:21:48+00:00June 9th, 2026|Endpoints News|
Lilly offers up to $1B for Alzheimer’s drug; Bial cuts failed Parkinson’s drugnews2026-06-09T14:37:24+00:00June 9th, 2026|Endpoints News|
Trodelvy misses in lung cancer, but Gilead and Merck have an HIV successnews2026-06-09T14:33:27+00:00June 9th, 2026|Endpoints News|
Endpoints Women in Biopharma: Nominate for 2026news2026-06-09T14:16:22+00:00June 9th, 2026|Endpoints News|
Pharma and biotech salaries: Top-paying companies of 2025news2026-06-09T14:00:39+00:00June 9th, 2026|Endpoints News|
Post-Hoc Live: How much is everyone in biopharma getting paid?news2026-06-09T12:16:09+00:00June 9th, 2026|Endpoints News|
WuXi AppTec added to Pentagon’s list of companies linked to Chinese military news2026-06-09T11:12:47+00:00June 9th, 2026|Endpoints News|
GSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6Bnews2026-06-09T06:39:59+00:00June 9th, 2026|Endpoints News|
